Wells Fargo & Company Ngm Biopharmaceuticals Inc Transaction History

Wells Fargo & Company

$410 Billion
Q1 2024

A detailed history of Wells Fargo & Company transactions in Ngm Biopharmaceuticals Inc stock. As of the latest transaction made, Wells Fargo & Company holds 15,407 shares of NGM stock, worth $0. This represents 0.0% of its overall portfolio holdings.

Number of Shares

15,407

Previous 13,931 10.6%

Holding current value

Previous $11,000 118.18%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	BUY	$1.17 - $1.92 $1,726 - $2,833	1,476 Added 10.6%	15,407 $24,000
Q4 2023 Feb 09, 2024	BUY	$0.6 - $1.31 $1,590 - $3,472	2,651 Added 23.5%	13,931 $11,000
Q3 2023 Nov 13, 2023	SELL	$1.05 - $3.37 $6,073 - $19,492	-5,784 Reduced 33.9%	11,280 $12,000
Q2 2023 Aug 15, 2023	BUY	$2.44 - $4.53 $22,011 - $40,865	9,021 Added 112.16%	17,064 $44,000
Q1 2023 May 12, 2023	BUY	$3.72 - $5.4 $26,199 - $38,032	7,043 Added 704.3%	8,043 $32,000

Q4 2022 Feb 13, 2023	SELL	$3.41 - $12.93 $1,565 - $5,934	-459 Reduced 31.46%	1,000 $5,000
Q3 2022 Nov 14, 2022	SELL	$12.59 - $17.67 $4,960 - $6,961	-394 Reduced 21.26%	1,459 $19,000
Q2 2022 Aug 12, 2022	SELL	$10.58 - $17.5 $114,465 - $189,332	-10,819 Reduced 85.38%	1,853 $24,000
Q1 2022 May 16, 2022	SELL	$13.81 - $18.6 $84,834 - $114,259	-6,143 Reduced 32.65%	12,672 $193,000
Q4 2021 Feb 14, 2022	BUY	$17.26 - $22.02 $9,026 - $11,516	523 Added 2.86%	18,815 $334,000
Q3 2021 Nov 15, 2021	SELL	$20.15 - $26.19 $504,555 - $655,797	-25,040 Reduced 57.79%	18,292 $384,000
Q2 2021 Aug 16, 2021	BUY	$15.06 - $30.03 $414,616 - $826,755	27,531 Added 174.24%	43,332 $854,000
Q1 2021 May 13, 2021	SELL	$24.99 - $31.93 $504,223 - $644,251	-20,177 Reduced 56.08%	15,801 $460,000
Q4 2020 Feb 09, 2021	SELL	$16.21 - $31.44 $245,338 - $475,844	-15,135 Reduced 29.61%	35,978 $1.09 Million
Q3 2020 Nov 05, 2020	SELL	$15.59 - $19.97 $509,465 - $652,599	-32,679 Reduced 39.0%	51,113 $813,000
Q2 2020 Aug 13, 2020	BUY	$11.97 - $23.47 $558,532 - $1.1 Million	46,661 Added 125.67%	83,792 $1.65 Million
Q1 2020 May 14, 2020	BUY	$10.0 - $19.51 $371,310 - $724,425	37,131 New	37,131 $458,000

Others Institutions Holding NGM

# of Institutions

Shares Held

36.7M

Call Options Held

1.1K

Put Options Held

200

View Full List

About NGM BIOPHARMACEUTICALS INC

Ticker NGM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 80,365,904
Description
NGM Biopharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of novel therapeutics to treat liver and metabolic diseases, retinal diseases, and cancer. The company's product candidates include Aldafermin, an engineered analog of human hormone fibroblast growth factor 19, which is in Phase IIb clinical trial...

More about NGM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Account

Wells Fargo & Company Ngm Biopharmaceuticals Inc Transaction History